Research Article
Association of Estimated Insulin Resistance with N-Terminal B-Type Natriuretic Peptide Concentration in Men with Metabolic Syndrome
Table 1
Clinical and biochemical characteristics of the study group.
| | Variables | Mean ± SD | Median, range |
| | Age (years) | 43.5 ± 9.6 | 44 (21.0–65.0) | | WC (cm) | 111.7 ± 8.9 | 113.0 (93.0–135.0) | | BMI (kg/m2) | 32.43 ± 3.70 | 31.2 (23.5–42.36) | | WHR | 1.09 ± 0.05 | 1.09 (0.95–1.21) | | SBP (mmHg) | 142 ± 16.4 | 149 (110–180) | | DBP (mmHg) | 90.5 ± 10.1 | 90.0 (70–110) | | NT-proBNP (pg/ml) | 27.9 ± 27.1 | 18.5 (5.0–101.1) | | TG (mg/dl) | 240.5 ± 124.7 | 210.0 (61.0–653.0) | | HDL-C (mg/dl) | 41.2 ± 8.7 | 40.5 (25.0–66.0) | | TC (mg/dl) | 220.9 ± 48.5 | 228.0 (107.0–342.0) | | LDL-C (mg/dl) | 132.2 ± 39.5 | 134.5 (28.0–234.0) | | FG (mg/dl) | 100.1 ± 10.0 | 99.0 (82.0–125.0) | | HbA1c (%) | 5.81 ± 0.36 | 5.75 (5.10–6.80) | | Creatinine (mg/dl) | 0.88 ± 0.12 | 0.90 (0.60–1.30) | | eGFR (ml/min/1,73 m2) | 102.3 ± 17.2 | 105.5 (65.0–157.0) | | Insulin (μU/ml) | 16.31 ± 9.49 | 13.6 (3.71–55.13) | | HOMA-IR | 4.10 ± 2.50 | 3.26 (0.89–13.07) |
|
|
BMI: body mass index; DBP: diastolic blood pressure; eGFR: estimated glomerular filtration rate; FG: fasting glucose; HbA1C: glycated hemoglobin; HDL-C: high-density lipoprotein cholesterol; HOMA-IR: homeostatic model assessment (insulin resistance); LDL-C: low-density lipoprotein cholesterol; NT-proBNP: amino-terminal pro-B-type natriuretic peptide; SBP: systolic blood pressure; TC: total cholesterol; TG: triglycerides; WC: waist circumference; WHR: waist/hip ratio.
|
